World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
114432
World Ranking
6345
National Ranking
3386

David L. DeMets publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David L. DeMets sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 356 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David L. DeMets D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David L. DeMets sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2013 - Member of the National Academy of Medicine (NAM)
  • 1998 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1986 - Fellow of the American Statistical Association (ASA)

Overview

David L. DeMets is affiliated with the University of Wisconsin-Madison in the United States. Their research spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Molecular Biology, and Statistics and Probability.

Their work covers a variety of topics related to clinical and epidemiological research. Key areas of study include Diabetes Treatment and Management, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Metabolism including connections to Diabetes and Cancer, Antiplatelet Therapy and Cardiovascular Diseases, Statistical Methods in Clinical Trials, and Meta-analysis and Systematic Reviews.

Several prominent publication venues feature David L. DeMets's research, with multiple articles appearing in The American Journal of Medicine, European Heart Journal, Clinical Trials, JACC Heart Failure, and Nature Medicine.

  • John J.V. McMurray (22 coauthored works)
  • Silvio E. Inzucchi (22 coauthored works)
  • Mikhail Kosiborod (22 coauthored works)
  • Scott D. Solomon (21 coauthored works)
  • Felipe A. Martínez (20 coauthored works)

Among the recent papers authored or coauthored, notable examples include:

  • "Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction" (2022), published in the New England Journal of Medicine
  • "Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial" (2021), published in European Journal of Heart Failure
  • "Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER" (2022), published in Nature Medicine
  • "Effects of dapagliflozin in DAPA-HF according to background heart failure therapy" (2020), published in European Heart Journal
  • "Genomic surveillance to combat COVID-19: challenges and opportunities" (2021), published in The Lancet Microbe

Recognized within professional circles, David L. DeMets has been elected to membership in the National Academy of Medicine in 2013. They were also named a Fellow of the American Association for the Advancement of Science in 1998 and a Fellow of the American Statistical Association in 1986.

Best Publications

  • 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Neil J Stone;Jennifer G Robinson;Alice H. Lichtenstein;C Noel Bairey Merz

  • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*

    Arthur J. Atkinson;Wayne A. Colburn;Victor G. DeGruttola;David L. DeMets

  • Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

    Michael R Bristow;LA Leslie A Saxon;John Boehmer;Steven Krueger

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Effect of carvedilol on survival in severe chronic heart failure.

    Milton Packer;Andrew Js Coats;Michael B Fowler;Hugo A Katus

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Fundamentals of Clinical Trials

    Lawrence M. Friedman;Curt D. Furberg;David L. DeMets

  • Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

    Milton Packer;Joseph R. Carver;Richard J. Rodeheffer;Russell J. Ivanhoe

  • Effect of carvedilol on survival in severe chronic heart failure

    M Packer;A.J.S Coats;M.B Fowler

  • The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and Risk of Diabetic Retinopathy When Age at Diagnosis Is Less Than 30 Years

    Ronald Klein;Barbara E. K. Klein;Scot E. Moss;Matthew D. Davis

  • Surrogate End Points in Clinical Trials: Are We Being Misled?

    Thomas R. Fleming;David L. DeMets

  • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

    Cynthia M. Tracy;Andrew E. Epstein;Dawood Darbar;John P. DiMarco

  • The Wisconsin epidemiologic study of diabetic retinopathy. VI: Retinal photocoagulation

    Ronald Klein;Barbara E.K. Klein;Scot E. Moss;Matthew D. Davis

  • The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

    Ronald Klein;Barbara E. K. Klein;Scot E. Moss;Matthew D. Davis

  • Interpretation of the evidence for the efficacy and safety of statin therapy.

    Rory Collins;Christina Reith;Jonathan Emberson;Jane Armitage

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study

    Milton Packer;Michael B. Fowler;Ellen B. Roecker;Andrew J.S. Coats

  • Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure.

    Milton Packer;Christopher M. O'Connor;Jalal K. Ghali;Milton L. Pressler

  • Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

    Love Rr;Mazess Rb;Barden Hs;Epstein S

  • 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Rick A. Nishimura;Catherine M. Otto;Robert O. Bonow;Blase A. Carabello

Frequent Co-Authors

Thomas R. Fleming
Thomas R. Fleming University of Washington
Curt D. Furberg
Curt D. Furberg Wake Forest University
Ronald Klein
Ronald Klein University of Wisconsin–Madison
Mikhail Kosiborod
Mikhail Kosiborod University of Missouri–Kansas City
Scot E. Moss
Scot E. Moss University of Wisconsin–Madison
John J.V. McMurray
John J.V. McMurray University of Glasgow
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Barbara E. K. Klein
Barbara E. K. Klein University of Wisconsin–Madison
Lars Køber
Lars Køber Copenhagen University Hospital
Charles H. Hennekens
Charles H. Hennekens Florida Atlantic University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine does not always require attending traditional, on-campus programs. Today, there are flexible online routes that can complement or expand your expertise in the medical and healthcare fields.

If you are interested in nutrition and wellness, an online bachelor's degree in nutrition can open doors to roles in dietetics, public health, and health education. For those seeking administrative or leadership roles in healthcare, consider enrolling in cahme accredited online mha programs. These programs are designed to provide the advanced management skills needed to lead healthcare organizations.

Registered nurses can advance their qualifications with rn to bsn programs no clinicals, offering the opportunity to complete degree requirements entirely online and around your work schedule. Nurses seeking the highest level of clinical expertise can enroll in dnp programs online to earn their Doctor of Nursing Practice degree.

Expanding your education through these online degrees can help you adapt to the evolving landscape of healthcare and unlock new career opportunities, all while balancing your existing commitments.

Best Scientists Citing David L. DeMets

Trending Scientists